In a nested case-control study, researchers showed that the use and treatment adherence to acetylcholinesterase inhibitors were associated with a decreased risk of osteoporotic fractures in elderly patients with Alzheimer's disease [23], which suggested that cholinergic fibers can impact bone remodeling in clinical data. This evidence concerns the gene ACHE and Alzheimer disease.